TrialThyroid : official journal of the American Thyroid Association2017

Defining Radioiodine-Refractory Differentiated Thyroid Cancer: Efficacy and Safety of Lenvatinib by Radioiodine-Refractory Criteria in the SELECT Trial.

Naomi Kiyota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.